We are live on
!
Find out more
US Bancorp Portfolio holdings
AUM
$82.4B
1-Year Est. Return
19.69%
This Fund
S&P 500
This Quarter
Est. Return
+8.01%
1 Year Est. Return
+19.69%
3 Year Est. Return
+59.6%
5 Year Est. Return
+69.89%
10 Year Est. Return
+246.63%
AUM
$39.1B
AUM Growth
+$2.42B
(+6.6%)
Cap. Flow
-$248M
Cap. Flow
% of AUM
-0.63%
Top 10 Holdings %
Top 10 Hldgs %
22.64%
Holding
3,845
New
218
Increased
1,110
Reduced
1,483
Closed
148
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell Mid-Cap ETF
IWR
|
+$45.6M |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$40.7M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$38.8M |
| 4 |
iShares S&P 500 Value ETF
IVE
|
+$35.5M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$34.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$80.2M |
| 2 |
Copart
CPRT
|
+$55.9M |
| 3 |
US Bancorp
USB
|
+$47.8M |
| 4 |
IBDK
iShares iBonds Dec 2019 Term Corporate ETF
IBDK
|
+$25.8M |
| 5 |
iShares Floating Rate Bond ETF
FLOT
|
+$17.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.27% |
| 2 | Financials | 10.78% |
| 3 | Industrials | 9.91% |
| 4 | Healthcare | 9.19% |
| 5 | Consumer Staples | 6.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
Evercore
EVR
$13.1B
| $1.34M | ﹤0.01% |
17,967
-1,644
| -8% | -$125K |
|
927
Fluor
FLR
$7.29B
| $1.34M | ﹤0.01% |
70,852
-7,648
| -10% | -$139K |
|
928
Texas Roadhouse
TXRH
$12.7B
| $1.33M | ﹤0.01% |
23,637
-1,635
| -6% | -$89.8K |
|
|
MNDT
929
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $1.33M | ﹤0.01% |
80,527
+118
| +0.1% | +$1.89K |
|
930
National Health Investors
NHI
$3.9B
| $1.32M | ﹤0.01% |
16,200
-1,683
| -9% | -$138K |
|
931
Lear
LEA
$7.19B
| $1.31M | ﹤0.01% |
9,571
-967
| -9% | -$120K |
|
|
PFPT
932
DELISTED
Proofpoint, Inc.
PFPT
| $1.31M | ﹤0.01% |
11,443
+3,010
| +36% | +$359K |
|
933
Expedia Group
EXPE
$31.2B
| $1.31M | ﹤0.01% |
12,123
-4,669
| -28% | -$548K |
|
934
B&G Foods
BGS
$285M
| $1.31M | ﹤0.01% |
72,956
-4,815
| -6% | -$81K |
|
935
NetEase
NTES
$76.5B
| $1.31M | ﹤0.01% |
21,290
+355
| +2% | +$20.8K |
|
936
Southwest Gas
SWX
$6.74B
| $1.3M | ﹤0.01% |
17,183
+96
| +0.6% | +$7.81K |
|
937
First Trust Smith Opportunistic Fixed Income ETF
FIXD
$3.23B
| $1.3M | ﹤0.01% |
25,118
+2,208
| +10% | +$116K |
|
|
SCWX
938
DELISTED
SecureWorks Corp Class A Common Stock
SCWX
| $1.3M | ﹤0.01% |
78,021
+1,799
| +2% | +$23.2K |
|
939
XPO
XPO
$25B
| $1.3M | ﹤0.01% |
47,127
+694
| +1% | +$19.1K |
|
940
Diamondback Energy
FANG
$57.6B
| $1.3M | ﹤0.01% |
13,984
-3,779
| -21% | -$314K |
|
941
iShares Government/Credit Bond ETF
GBF
$133M
| $1.3M | ﹤0.01% |
11,021
+6,839
| +164% | +$809K |
|
942
Live Nation Entertainment
LYV
$41.2B
| $1.29M | ﹤0.01% |
18,101
+8,893
| +97% | +$603K |
|
|
NBL
943
DELISTED
Noble Energy, Inc.
NBL
| $1.28M | ﹤0.01% |
51,584
-6,840
| -12% | -$145K |
|
944
Wrap Technologies
WRAP
$94.8M
| $1.28M | ﹤0.01% |
200,000
| – | – |
|
945
Dorman Products
DORM
$4.01B
| $1.28M | ﹤0.01% |
16,848
-2,625
| -13% | -$198K |
|
946
ING
ING
$93.8B
| $1.28M | ﹤0.01% |
105,785
+43,864
| +71% | +$502K |
|
947
Mercury Systems
MRCY
$6.2B
| $1.27M | ﹤0.01% |
18,412
+71
| +0.4% | +$5.12K |
|
948
Fresenius Medical Care
FMS
$13.2B
| $1.27M | ﹤0.01% |
34,519
-7,618
| -18% | -$270K |
|
949
US Physical Therapy
USPH
$1.14B
| $1.27M | ﹤0.01% |
11,096
-1,033
| -9% | -$129K |
|
|
TARO
950
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $1.27M | ﹤0.01% |
14,421
-756
| -5% | -$63.8K |
|
Similar funds
US Bancorp's Q4 2019 Portfolio in Review
As of Q4 2019, US Bancorp held 3,845 positions worth $39.1B, up 6.6% from $36.7B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
US Bancorp's Q4 2019 filing shows 218 new, 1,110 increased, 1,483 reduced and 148 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 611,031 shares worth $1.84M. The largest sale was Celgene Corp, an estimated $80.2M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Industrials.
- US Bancorp's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 611,031 shares worth $1.84M.
- US Bancorp added most to iShares Russell Mid-Cap ETF in Q4 2019, an estimated $45.6M increase.
- US Bancorp's biggest Q4 2019 reduction was Copart, cutting an estimated $55.9M.
- US Bancorp fully exited Celgene Corp in Q4 2019, selling an estimated $80.2M.
- US Bancorp's ten largest holdings make up 23% of its $39.1B portfolio in Q4 2019.
- US Bancorp opened 218 new positions and closed 148 in Q4 2019.
- US Bancorp's portfolio value rose 6.6% quarter-over-quarter to $39.1B.
Based on US Bancorp's 13F filing for Q4 2019, filed 4 Feb 2020.